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ApoptosisAnalyses of knockout and mutant transgenic mice as well as in vitro studies demonstrated a complex role of
FADD in the regulation of cell fate. FADD is involved in death receptor induced apoptosis, cell cycle
progression and cell proliferation. In a search for mechanisms that might regulate FADD functions, we
identiﬁed, upon the screening of a lambda-phage cDNA library, calmodulin (CaM) as a novel FADD
interacting protein. CaM is a key mediator of signals by the secondary messenger calcium and it is an
essential regulator of cell cycle progression and cell survival. Here, we describe the identiﬁcation and
characterization of two calcium dependent CaM binding sites in the alpha helices 8–9 and 10–11 of FADD.
Phosphorylation of human FADD at the C-terminal serine 194, by casein kinase I alpha (CKIα), has been
shown to regulate FADD-dependent non-apoptotic activities. Remarkably, we showed that both FADD and
CaM are CKIα substrates and that in synchronized HeLa cells, FADD, CaM and CKIα co-localize at the mitotic
spindle in metaphase and anaphase. Moreover, complementation experiments in Jurkat FADD−/− T cells
indicated that: a) cells expressing FADD mutants in the CaM binding sites are protected from Taxol-induced
G2/M cell cycle arrest; b) FADD/CaM interaction is not required for Fas receptor-mediated apoptosis
although Fas and CaM might compete for binding to FADD. We suggest that the interplay of FADD, CaM and
CKIα may have an important role in the regulation of cell fate.ADD, murine FADD; dFADD,
r domain; DD, death domain;
kinase I alpha; TNFRI, tumor
re, Consiglio Nazionale delle
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FADD with the N-terminal death effector domain (DED) and the C-
terminal deathdomain (DD), alignedwithone another in anorthogonal,
tail-to-tail fashion in solution [1], is a mediator of apoptotic signaling.
FADD by homotypic interactions with the DDs of activated death
receptors such as Fas and theDEDof the initiator procaspases -8 and -10
is a crucial component of the death inducing signaling complex (DISC)
[2]. Besides the very well known role in pro-apoptotic signaling, FADD
has also been implicated in multiple non-apoptotic functions [3]
including autophagic death [4], NF-kB activation [5], innate immunity
by regulation of type I interferon production [6], proliferation and cell
cycle progression [7–17]. The analyses of knockout and mutant mice
have indicated that FADD is required in mitogen- or antigen-induced
activation and proliferation of mature T cells. FADD-null mutation inmice is embryonic lethal [7,18], FADD−/− T cells from RAG-1−/−
reconstituted chimeras or tissue-speciﬁc knockout mice showed
impaired proliferation and cell cycle progression upon activation [7–
12]. Transgenic expression of a dominant-interfering mutant of FADD
inhibited mitogen- or antigen-induced activation and proliferation of
mature T cells [8–11]. The study of conditional FADD.GFP knockoutmice
further demonstrated that FADD plays an essential role in maintaining
peripheral T cell homeostasis and in regulating both apoptotic and
proliferation signals [15].
Interestingly, several reports indicated the involvement of FADD
phosphorylation in the regulation of cell cycle entry and progression
[14,16,17]. Casein kinase I alpha (CKIα) has been identiﬁed as a kinase
that phosphorylates FADD (pFADD) and that co-localizeswith pFADD at
the spindle poles during mitosis [16]. All CKIα isoforms (CKIα, CKIαS,
CKIαL and CKIαLS [19,20] have been shown to phosphorylate the C-
terminal region of FADD at S194 [16]. Remarkably, inhibition or RNAi-
based knock down of CKIα caused resistance to Taxol-induced G2/M
arrest [16]. CKI comprises a large family of ubiquitouspleiotropic serine/
threonine protein kinases, whose members, encoded by seven genes in
the human genome (α, β, γ1, γ2, δ and ε), are variously implicated in a
number of cellular functions including cell cycle and apoptosis
regulation [21,22].
Three human genes (CALM1, CALM2 and CALM3), located on
different chromosomes, encode for an identical protein, CaM. CaM is a
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served small acidic protein that mediates a plethora of fundamental
processes, by its association with structurally and functionally diverse
effectors [23–26]. CaM is composed of two globular domains linked by
a central ﬂexible α-helix; each globular domain contains two helix–
loop–helix motifs, named EF-hands, which bind calcium ions [27,28].
Upon calcium binding CaM undergoes major conformational changes
from a mainly hydrophilic closed state to an open conformation,
exposing large hydrophobic binding pockets [29]. Through these
hydrophobic pockets, along with other interacting surfaces from both
the N and C lobes, CaM binds diverse structures, altering the prop-
erties of kinases, phosphatases, phosphodiesterases and ion channels
among others. Structural studies revealed that CaM can adopt a wide
spectrum of conformations to interact with different targets and this
explains its involvement in a broad range of signaling and phosphor-
ylation pathways [30–33]. Furthermore, it has been shown that CaM
itself is phosphorylated on the central helix (Thr79 and Ser81) and on
the third EF hand (Ser101) in vivo [34,35]. The same residues and
Thr117 can also be phosphorylated in vitro by CK2 [34], a constitutive
active highly pleiotropic serine/threonine kinase implicated in signal
transduction and gene expression [36]. Interestingly phosphorylation
of CaM by CK2 has been reported to variably affect its interaction with
several targets [34,37,38].
Here, we identify and characterize two putative calcium depen-
dent CaM binding sites, in α helices 8–9 and 10–11 of FADD.
Moreover, we demonstrated that: a) CaM interacts in vitro with CKIα
and that both FADD and CaM are CKIα substrates; b) FADD, CaM and
CKIα co-localize at the mitotic spindle in HeLa cells; c) cells
expressing FADD mutants, in the CaM binding sites, are protected
from Taxol-induced G2/M cell cycle arrest; d) FADD/CaM interaction
is not required for Fas receptor-mediated apoptosis although Fas and
CaM might compete for binding to FADD.
2. Materials and methods
2.1. Cells, antibodies, and reagents
The following human cell lines: HuT78 (ATCC), T cell lymphoma;
U937 (ATCC), monocytic/macrophage, Jurkat, T cell leukemia, clone JA3
and I2.1 (FADD−/−) (ATCC), respectively very sensitive or resistant to
Fas-mediated apoptosis and kindly provided by Dr. PT Daniel, were
cultured in RPMI 1640 medium (BioWhittaker). The epithelial cells,
HeLa, HeLaS3, human embryonic kidney (Hek) 293T cells and Phoenix
amphotropic Hek293T (ATCC) package cell line were cultured in
Dulbecco's modiﬁed Eagle's medium, 4.5 g/l glucose. The tissue culture
media were supplemented with 10 mM Hepes, 1 mM L-glutamine,
100 U/ml penicillin/streptomycin and heat inactivated 5% (HeLaS3,
Hek293T) or 10% (all other cell lines) fetal bovine serum (FBS). All cells
were cultured at 37 °C in a 5% CO2 humidiﬁed incubator. Calmodulin-
sepharose® 4B; protein G-sepharose Fastﬂow; protein A-sepharose CL-
4B and glutathione sepharose 4B were from Amersham Biosciences.
Primary antibodieswere reactivewith: glutathione S-transferase (GST),
goat polyclonal antibody from Amersham Biosciences; FADD, mouse
IgG1 cloneA66-2 fromBectonDickinson, BDPharmingen (San Jose, CA),
mouse Ig1 clone 1 from BD Transduction Laboratories, phospho FADD
(Ser194) rabbit polyclonal from Cell Signaling Technology (Beverly,
MA), FADD rabbit polyclonal antibody from Upstate Biotechnology Inc
(UBI, Lake Placid, NY); calmodulin, mouse IgG1 from UBI and CaM I
rabbit polyclonal from Santa Cruz Biotechnology, Inc.; CKIα, goat
polyclonal antibody (C-19, Santa Cruz); λ phage, rabbit polyclonal,
kindly provided by Drs. A Luzzago and R Cortese; Flag, M2 mouse IgG1
(Sigma-Aldrich); HA, clone 12CA5 mouse IgG2b (Roche Applied
Science); Fas, mouse IgM clone CH-11 from UBI, mouse IgG1 clone
DX2 from BD Pharmingen and rabbit polyclonal antibody, N18 (Santa
Cruz Biotechnology). Sheep anti-mouse and anti-rabbit Ig horseradish
peroxidase (HRP)-conjugated were purchased from Amersham Bios-ciences, goat anti-murine IgG1- and IgG2b-HRP were from Caltag
Laboratories, anti-goat Ig HRP-conjugated was from Sigma-Aldrich.
Alexa 594 and 488 labeled goat anti-mouse and anti-rabbit Ig and
donkey anti-goat were from Molecular Probes; anti-rabbit TRITC and
FITC conjugated antibodies were from Jackson ImmunoResearch
Laboratories, Inc; CaM recombinant protein was from UBI and CKI
fromPromega. Protease and phosphatase inhibitorswere obtained from
Roche Applied Science and Sigma-Aldrich, Taxol from Sigma-Aldrich
and CKI-7 from Toronto Research Chemical.
2.2. Plasmids
pcDNA3-AU1.FADD vector, coding for a full-length human FADD
protein, previously described [39] and kindly provided by Dr VM Dixit
was used as template to produce, by PCR, all FADD mutants. The PCR
products were cloned in pGEX-4T1 or pGEX4-T3 (Amersham Pharma-
cia), pcDNA3(Invitrogen), pEF-HA [40], pFLAG-CMV-2 (Sigma-Aldrich),
pEGFP-N1 (Clontech) expression vectors. Kozak and Flag coding
sequences were included at the N-terminal of the FADD mutants in
the pBABE-puro expression vector, kindly provided byDrMCaruso. The
quick-change site-directed mutagenesis kit (Stratagene) was used to
generate pointmutations inpGEX-FADD. TheEcoRI–XhoIDNA fragment
of the IMAGE clone 3689007 was subcloned in pCMV-Tag2B (Strata-
gene) to obtain a TRADD mammalian expression vector with a N-
terminal Flag site. pQ50-Fas (1–67), coding for a His-tag extra cellular
region of the Fas receptor containing the N-terminal 67 amino acids of
the mature Fas receptor, was produced by PCR using as template the
pGEX-FasExtra plasmid [41]. The expression vectors, previously
described, pET-15b-CaM [29], pT7.7-H6-CKIα, encoding Danio rerio
CK1α [19] and pV367, encoding full-length human HA-tagged CK1αS
[42] were kindly provided by Drs M Ikura, VH Bustos and DM Virshup.
DNA sequencing analysis was performed, on all expression vectors,
using the Big-Dye terminator v3.1 cycle sequencing kit (Applied
Biosystems) with an ABI 3100 genetic analyzer.
2.3. Protein expression
Recombinant GST- and His-tagged proteins were produced in BL21
(DE3) E. coli as described in Supplemental data. A coupled
transcription/translation kit (Promega) was used to produce 35S-
Met-labeled proteins according to the manufacturer's instructions.
2.4. CaM and GST pull-down assays
CaM binding assays were performed essentially as previously
described [43]. Brieﬂy, E. coli GST- and His-proteins, or 35S-Methionine
labeled proteinswere diluted in binding buffer (50 mMTris–HCl pH7.6,
120 mM NaCl, 1% Brij 98) and incubated with calmodulin-sepharose®
4B, or glutathione sepharose beads for 2 h at 4 °C, in presence of either
CaCl2 or EGTA, as indicated. After ﬁvewashes, interacting proteins were
either eluted in 1 M NaCl, 2 mM EGTA or directly in reducing Laemmli
sample buffer. Proteins were separated by SDS-PAGE and gels either
exposed, upon coomassie staining, to PhosphorImager screens or
blotted to nitrocellulose membranes (Amersham Biosciences). In
Western blot with CaM antibody, membranes were treated with 0.2%
glutaraldehyde-TBS for 45 min, blocked in 2% BSA-TBS and then
incubated 16 h with CaM speciﬁc antibody at 4 °C in TBS containing
0.2% Tween 20 (TTBS) followed by incubation with HRP-conjugated
secondary antibody for 1 h at room temperature in TTBS and developed
using enhanced chemiluminescence (ECL) detection and membrane
exposure to Kodak Biomax MR ﬁlms (Amersham Bioscience).
2.5. λ Phage clone biopanning procedure
An aliquot (1010 pfu) of a human brain cDNA expression library
displayed on λ phage, kindly provided by Drs. A Luzzago and R Cortese
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coupled to glutathione sepharose beads. Unbound phages were
removed by washing ﬁve times with PBS pH7.2–0.5% Tween 20,
further washed twice with λ extraction buffer (100 mM NaCl, 10 mM
MgSO4, 35 mM Tris–HCl pH7.5), and ﬁnally resuspended in λ
extraction buffer (100 µl). Supernatant and resin were used to
determine respectively the amount of detached and adsorbed phages
in each round of selection. Following four rounds of selection, ELISA
was used to determine the enrichment in GST-FADD interacting
clones. Next, 100 plaques were arbitrarily isolated from LB plates;
each plaquewas dissolved in λ phage extraction buffer and assayed by
ELISA.
2.6. λ Phage ELISA and sequencing
Small scale phage preparations were analyzed for binding to GST-
FADD by a sandwich ELISA with anti-GST coated plates and λ phage
polyclonal antibody (see Supplemental data for details). The cDNA
insertswerePCRampliﬁed and selected fornucleotide sequenceanalysis.
2.7. CaM blot overlay
Xenopus laevisHis–CaM puriﬁed proteinwas biotinylated and used
in blot overlay assays as described in Supplemental data.
2.8. FADD pull-down assays with cell lysates
5×107 cells were lysed for 30 min on ice in 20 mM Hepes pH7.4,
100 mM NaCl, 1 mM MgCl2, 0.1% NP40, fresh 1 mM DTT and protease
and phosphatase inhibitors (1 μg/ml aprotinin, 2 μg/ml leupeptin,Fig. 1. GST-FADD mutants and characterization of FADD reactive λ phage. A: Schematic repr
domain (DD) and the S194 phosphorylation site of human FADD are shown. mFADD and d
FADD reactive λD-protein phages upon afﬁnity selection. The O.D. (optical density) values ar
a brain cDNA library with GST-FADD bound to glutathione sepharose beads, were assayed for
interacting λ phage D-fusion proteins by CaM speciﬁc antibody (UBI). rCaM (100 ng) indica
phage clone lacking any CALM cDNA sequence. Molecular weight standards (BenchMark™ p
clone binding proﬁles. ELISA was performed with GST-FADD deletion mutant coated plates1 mM PMSF, 1 mM Na3VO4, 20 mM β-glycerophosphate, 10 mM Na-
Pyrophosphate). The cells were broken up using 15 strokes with a
Dounce homogenizer and the cell lysates, centrifuged at 3000×g for
10 min at 4 °C, were precleared with sepharose beads 1 h at 4 °C and
incubated with a slurry of nickel-beads-bound His–CaM or control
His-proteins, i.e. His-Fas (aa 1–67) or His-cyclophilin (kindly provided
by Drs AR Troiani and D Cioli) in lysis buffer containing 2 mM CaCl2.
The beads were washed ﬁve times with lysis buffer containing 2 mM
Ca2+ and collected by centrifugation at 3600×g. Bound proteins,
recovered by boiling for 3–5 min in reducing Laemmli sample buffer,
were subjected to SDS-PAGE and Western blot analysis.
2.9. In vitro kinase assays
Puriﬁed GST-FADD proteins, recombinant CaM (UBI) or His–CaM
(2–3 μg) were incubated in 30 μl of kinase buffer (50 mM Tris–
HCl pH7.5, 10 mM MgCl2, 1 mM fresh DTT) with 5 μCi of γ-32P-ATP
(3000 Ci/mmol Amersham Bioscience) and 5 μl of His-CKIα or 5 U of
commercial CKI (Promega) for 30 min at 37 °C. The samples were
analyzed by SDS-PAGE, coomassie staining and PhosporImager
exposure. When the kinase source was cell extracts, 5–10 μg of GST-
FADD or His–CaM bound to beads was incubated for 1.5 h at 4 °C with
300–500 μg of whole cell lysates (precleared by incubation for 15 min
at 4 °C with glutathione sepharose or Ni-NTA agarose beads) essen-
tially as previously described [16].
2.10. Transfection, co-immunoprecipitation and apoptosis assays
Hek293T cells were transfected by the calcium-phosphate precip-
itation method and Jurkat T cells by electroporation essentially asesentation of GST-FADD deletion mutants. The death effector domain (DED), the death
FADD indicate respectively the murine and Drosophila FADD protein. B: Enrichment of
e shown; pools of λ phages, obtained after each cycle of selection-ampliﬁcation (I–IV) of
binding to GST and GST-FADD coated plates by ELISA. C:Western blot detection of FADD
tes the recombinant commercial CaM (UBI) used as positive control. F2 is a lysate of a λ
restained protein ladder, Invitrogen) are indicated. D: Summary of the isolated λ phage
.
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without FBS and antibiotics, were electroporated at 250 V and 960 μF
with 15 μg of plasmid DNA using a Bio-Rad Gene Pulser. One hourFig. 2. Ca2+-dependent binding of FADD to CaM-sepharose. Identiﬁcation of two CaM bindin
sites in human FADD full-length protein, the probability scores, assigned as described in the te
control (Ctrl) beads (protein A-sepharose) in binding buffer with 2 mMCa2+ or EGTA. Bound
analyzed by SDS-PAGE andWestern blot with GST speciﬁc polyclonal antibody. I, indicates the
incubatedwith CaM-sepharose beads in binding bufferwith Ca2+ or EGTA as indicated. Bound
analyzed by SDS-PAGE and autoradiography. The inputwas 1/20 of the translation reaction us
sepharose in binding buffer supplemented with Ca2+ or EGTA as in B; I, E and R indicate the in
arrow, in the top panel, indicates the aggregates of GST-FADD.DED on the beads. E: Binding of
Binding of GST-FADDα7–9 (aa 79–136) and GST-FADDα10–12 (aa 133–189) to CaM-sephar
at least three independent experiments.upon transfection, healthy cells were recovered by Ficoll gradient and
cultured in 10% FBS complete RPMI medium. For the co-immunopre-
cipitation experiments, transfected cells were lysed in 50 mM Tris–g sites in FADD.DD. A: CaM target database analysis. Prediction of putative CaM binding
xt, are indicated. B: GST and GST-FADD proteinswere incubatedwith CaM-sepharose or
GST proteins were eluted in 1 MNaCl, 2 mM EGTA and 1/10 of the eluted proteins were
inputs (1/20). C: 35S-Met-FADD, produced by in vitro transcription and translation, was
GSTproteinswere eluted in reducing Laemmli sample buffer and50%of the reactionwas
ed in the binding assay. D: GST-FADD.DED andGST-FADD.DDwere incubatedwith CaM-
puts (1/20), eluates (1/10) and resins (1/6) (post-elution) of the binding reactions. The
GST-FADD and GST-FADD.DEDF25Y to CaM-sepharose and control beads as in B andD. F:
ose beads with Ca2+ (2–0.02 μM) or EGTA (2 mM). The data shown are representative of
Table 1
FADD mutants assayed for CaM binding.
GST-FADD
































+/− indicates no signal in blot overlay and b25% of FADD wild type in CaM-Sepharose
pull-down assays.
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protease and phosphatase inhibitors for 30 min at 4 °C. The samples
were centrifuged at 15,000×g for 20 min and incubated with DX2,
HA, control murine Ig or IgG1monoclonal antibodies bound to protein
G-sepharose. In the complementation experiments, transfected Jurkat
T cells were exposed to a Fas agonistic antibody, CH-11 (100 ng/ml)
for 8–16 h at 37 °C and apoptosis induction was determined, upon
staining with propidium iodide (50 mg/l) in 0.1% sodium cytrate
plus 0.1% Triton X-100, on a FACSCalibur ﬂow cytometer using the
CellQuest software (BD Bioscience).
2.11. HeLa cell synchronization and immunoﬂuorescence analysis of
mitotic cells
To enrich cultures inmitosis, HeLa cells were plated, on poly-lysine
pretreated coverslips, at 35% conﬂuence and synchronized by double
thymidine block essentially as previously described [46]. Brieﬂy, cells
were treated with thymidine (Sigma-Aldrich, 2 mM) for 16 h, and
then thymidine was washed out and replaced with fresh medium
containing 30 μM deoxycytidine for 10 h. The thymidine block was
repeated once and the cells released for 9–10 h were processed for
immunoﬂuorescence analysis. Brieﬂy, the cells washed twice in buffer
A (100 mMHepes, pH7.3, 110 mMKOAc, 2 mMMg(OAc)2, 2 mMDTT,
protease inhibitors), were permeabilized for 5 min in ice cold buffer A
containing 12.5 μg/ml digitonin (Calbiochem) at room temperature,
washed again twice with buffer A and ﬁxed in the same buffer
containing 6.7% paraformaldehyde for 15 min at room temperature.
Next, the cells were incubated with FADD (UBI or BD Transduction
Laboratories), CaM (Santa Cruz or UBI) and CKIα (Santa Cruz) reactive
antibodies as indicated. Nuclei were counterstained, when required,
with the DNA dyes bis-benzimide Hoechst 33258 (Calbiochem) or
DAPI (4′-6-Diamidino-2-phenylindole) (Sigma-Aldrich). Samples
were examined with an Olympus AX70 ﬂuorescence microscope
and images were recorded with a CCD camera and processed using a
DeltaSystem and Adobe Photoshop software.
2.12. Retroviral complementation of Jurkat FADD−/− T cells and
Taxol-induced G2/M cell cycle arrest
High-titer retrovirus stocks were produced in the Phoenix ampho-
tropic packaging Hek293T cell line according to a procedure previously
described (http://www.stanford.edu/group/nolan/retroviral_sys-
tems). Brieﬂy, 2.5×106 cells were transfected using calcium-phosphate
method with 10 μg of retroviral plasmids (pBabe-puro), supernatants
were collected and ﬁltered (0.2 μm) at 48 h. Jurkat FADD−/− cells
(5×105) were incubated for 12 h with 1 ml of retrovirus-containing
medium supplemented with polybrene (5 µg/ml) and then selected
with puromycin (1 µg/ml) 48 h upon infection. The resulting puromy-
cin-resistant cell populations were then further characterized. For
cell cycle analysis, cells were synchronized by double thymidine
block essentially as described above with minor changes. Brieﬂy,
cells were treated with thymidine (0.56 mM) for 18 h, released in
30 μMdeoxycitydine for 9 h, blocked againwith thymidine for 15 h and
ﬁnally treated 4–5 h, upon the second release with Taxol (5–20 nM)
for 12–16 h.
3. Results
3.1. Identiﬁcation of CaM as a novel FADD interacting partner
A phage-displayed human brain cDNA library [44] was screened
to identify novel FADD interacting proteins. GST-FADD, containing the
protein–protein interaction domains DED and DD and the C-terminal
region of 27 amino acids (aa 182–208) including the S194 phos-
phorylation site, (Fig. 1A) was used as bait. An enrichment in GST-
FADD reactive clones was observed at the IV selection cycle by ELISA(Fig. 1B). FADD reactive clones were isolated and further character-
ized. Twenty-eight clones contained CALM1 or 2 cDNAs, of these 12
were coding for a full-length protein (F100-like) and 16 for the C-
terminal domain of CaM lacking the N-terminal 80 amino acids (F3-
like). Western blot analysis of representative λ phage clones is shown
in Fig. 1C. Next, F3-like and F100-like representative clones were
tested in ELISA with GST-FADD deletion mutants (Fig. 1D). The F2
clone, lacking any CALM cDNA sequence, was used as negative
control. The results conﬁrmed the interaction of the phage lysates
with GST-FADD and indicate that the DD contains CaM interacting
site(s).
3.2. Identiﬁcation of calcium dependent CaM binding sites in FADD
The database of Dr. Ikura's laboratory (http://www.calcium.uhnres.
utoronto.ca/ctdb) was used to search for putative CaM binding sites in
FADD. Computational tools assign to putative binding sites, within a
protein sequence, scores based on α-helical tendency, hydropathy,
residue weight, net charge, hydrophobic residue content and the
occurrence of particular residues. Scores assigned to a twenty-residue
window are normalized for the entire sequence. Themost likely binding
site is highlighted by a series of 9s [47]. In FADD, three putative binding
siteswerepredicted; one in theDED in theαhelices 2–4 and connecting
loops (aa 20–47) [48] and two in the C-terminal DD [49,50], respectively
in the α helices 8–9, including the turn and coil fragments preceding α
helix 8, (aa 107–126) and in the α helices 10–11 with their connecting
loops (aa 145–166) [1] (Fig. 2A). Sequence analysis of FADD fragments,
including FADD.DED, FADD α helices 7–9 and FADD α helices 10–12,
conﬁrmed the prediction of CaM binding sites and assigned a 9 score to
all three. To demonstrate the direct binding between FADD and CaM, to
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independent and to identify the CaM binding sites in FADD, we
performed binding assays with: A) CaM-sepharose and soluble GST-
FADD fusion proteins, or 35S-Met-labeled FADD proteins produced by in
vitro transcription and translation; B) GST-FADD proteins bound to
glutathione sepharose beads and 35S-Met-labeled CaM protein or His–
CaM protein puriﬁed from E. coli. Both GST-FADD and 35S-Met-FADD
speciﬁcally bound to CaM-sepharose in a calcium dependent fashion
(Fig. 2B, C). Moreover, CaM-sepharose bound GST-FADD.DD but not
GST-FADD.DED (Fig. 2D). GST-FADD.DED was poorly soluble and
aspeciﬁcally bound to resins (Fig. 2D); however, binding assays with a
more soluble DED mutant (F25Y), previously used to solve its
structure [49], conﬁrmed that this domain does not interact with
CaM-sepharose (Fig. 2E). Finally, two deletion mutants containing
respectively the α helices 7–9 and 10–12 of FADD [49,50] (Fig. 1A)Fig. 3. Characterization of the CaM binding sites in FADD. A: α helices 8–9 CaM-BS and α1
binding site (CaM-BS) in the helices α8–9 and GST-FADD aa 127–208 containing the CaM-B
on SDS-PAGE, transferred to nitrocellulose and assayed for binding to His–CaM conjugated to
the western blot with biotin-conjugated His–CaM detected by avidin-HRP and ECL. B: GST-
analyzed by ponceau staining (top) and blot overlay (bottom) as in A. C: CaM-sepharose pu
indicates the inputs. Bound proteins were detected by Western blot with anti-GST antibodbound to CaM-sepharose in a buffer containing physiological concen-
tration of Ca2+ (2–0.02 μM) but not in presence of EGTA (Fig. 2F);
protein A-sepharose beads were used as negative control (data not
shown). Overall these results demonstrate that at least two binding
sites, located in the DD, are present in FADD. In reciprocal experiments,
GST-FADD bound to glutathione sepharose beads pull-down 35S-Met-
CaM or X. laevis His–CaM in a calcium dependent fashion (see
Supplemental data Fig. S1A, B).
3.3. Identiﬁcation of FADD mutations that interfere with FADD–CaM
interaction
CaMbindingmotifs are quite diverse and have been grouped into 3
related classes, namely the 1–14, 1–10 and 1–16 motifs in addition to
the Ca2+-independent IQ motif; each group contains several0–11 CaM-BS indicate respectively GST-FADD aa 2–136 containing the predicted CaM
S in the helices α10–11. Wild type (wt) or point alanine mutants were electrophoresed
biotin in blot overlay. In the top panel is shown the ponceau staining and in the bottom
FADD full-length proteins wild type (wt) or with double aminoacid substitutions were
ll-down with GST-FADD wild type (wt) or double point mutants as described in Fig. 2, I
y. The data shown are representative of at least three independent experiments.
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aromatic residues that anchor the target protein to the two lobes of
Ca2+.CaM (http://www.calcium.uhnres.utoronto.ca/) [47]. The two
predicted CaM binding sites in FADD were scanned for known and
described motifs. The amino acids sequence in α helices 8–9 (aa 107–
126) contains a putative 1-5-8-14 motif with a net charge of +4 (aa
108–121 VgkdWrrLarqlkV) and an overlapping 1-5-10 motif with a
net charge of +4 (aa 109–121 gkdWrrlArqlkV). The site in α helices
10–11 (aa 145–166), with a higher probability prediction score, has a
net charge of +2 and hydrophobic residues with distances
compatible with putative 1–14 or 1–16 motifs. However, the net
charge of these motifs is lower than the one of analogue motifs listed
in the CaM Target Database due to acidic residues present within the
sequence.
To further characterize the CaM binding sites, we designed a series
of mutations to perturb the binding properties of FADD (Table 1).
Single or double alanine substitutions, in either one or both putative
CaM binding sites, replaced bulky hydrophobic residues (V108,W112,
V121, W148, V158, L161, and V162) or basic residues (R114, R146,
and K153). In particular, group A (GST-FADD aa 2–136) includes
mutants in the α helices 8–9; group B (GST-FADD aa 127–208) in the
α helices 10–11; group C (GST-FADD full length) includes the wild
type and mutants with single or double Ala substitutions within the
two putative CaM binding sites (Table 1). All GST-FADD fusion
proteins were assayed by blot overlay with biotin-labeled His–CaM.
The results demonstrated that W112A, R114A, R146A, W148A and
K153A mutations in the GST-FADD truncated fusion proteins of group
A and B abrogate His–CaM interaction, indicating that the binding site
prediction was correct (Fig. 3A). Moreover, blot overlays and CaM-
sepharose binding indicated that the following double mutations in
FADD, W112A/R146A, W112A/W148A, W112A/K153A, R114A/
R146A, R114A/W148A and R114A/K153A impair CaM interaction
(Fig. 3B, C). As expected for the presence of two CaM binding sites, all
GST-FADD proteins with a single point mutation, mapping to either
one of the CaM binding sites, bound His–CaM as the wild type protein
(Table 1).Fig. 4. CaM interacts with unphosphorylated and phosphorylated FADD protein. Ni-NTA
agarose beads with bound His–CaM or control (Ctrl) His-proteins cyclophilin (A) or
His-Fas (aa 1–67) (B) were incubated with cell lysates of HeLaS3 (A, B), HuT78 (A) and
U937 (A) human cell lines. The beads were boiled in reducing Laemmli sample buffer
and the bound proteins were analyzed by 12% SDS-PAGE and Western blot with FADD
(Transduction Laboratories or UBI) (A) or Phospo FADD S194 (Cell Signaling
Technology) (B) reactive antibodies, followed by HRP-conjugated secondary anti-
bodies. TL, indicates total cell lysates, none, Ni-NTA agarose beads. Positions of the
molecular weight standards (BenchMark™ prestained protein ladder, Invitrogen)
are indicated. The data shown are representative of at least three independent
experiments.3.4. CaM interacts with phosphorylated and unphosphorylated FADD
protein
In order to see whether endogenous human FADD protein was
binding to CaM, cellular extracts of hematopoietic (HuT78), epithelial
(HeLaS3) and monocytic/macrophagic (U937) cell lines were incu-
bated with His–CaM-nickel beads or control His-proteins. Western
blot analyses showed that both unphosphorylated and phosphory-
lated FADD bind CaM (Fig. 4A, B). In Fig. 4A the characteristic doublet
of FADD, where the low mobility band is due to FADDFig. 5. FADDmutants in the CaM binding sites: in vivo analysis. A: Immunoprecipitation
of NP40 soluble Hek293T cell fractions with DX2, anti-Fas or matched mIgG1 control
monoclonal antibodies and Western blot with anti-Fas (N18 polyclonal anti-rabbit
antibody from Santa Cruz) (a) and anti-HA antibody (b). Ctrl indicates single
transfection with Fas expression plasmid. B: Immunoprecipitation of NP40 soluble
Hek293T cell lysates with anti-HA (clone 12CA5) (a) or control mIgG (b) monoclonal
antibodies and Western blot with anti-Flag (Sigma-Aldrich) (a, b). Ctrl in a and b
indicates single transfection with pEF-HA empty plasmid, * indicates the Ig heavy chain.
C: Percentage of apoptotic cells, measured by propidium iodide staining and
cytoﬂuorimetric analysis, following treatment with anti-Fas (CH-11) antibody of Jurkat
FADD−/− I2.1 T cells electroporated with the HA-FADDmutants indicated. Results are
the average±SD of three independent experiments. Grey bars indicate untreated and
black bars CH-11 treated samples. Ctrl indicates cells transfected with an empty vector.
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phospho FADD antibody is shown. The results are in agreement with
CaM binding sites located N-terminal to the S194 phosphorylation
site.
3.5. CaM binds to murine and Drosophila FADD death domains
To investigate whether FADD/CaM interaction was evolutionarily
conserved, murine and Drosophila GST-FADD proteins were used in
CaM-sepharose pull-down assays. The results demonstrated that both
proteins interact with CaM-sepharose in a Ca2+-dependent fashion
(see Supplemental data Fig. S2A, B), while no binding was detected
with control beads (data not shown). Multiple sequence alignment of
orthologous FADD proteins showed high conservation of the CaM
bindingmotifs (see Supplemental data Fig. S2C) and interestingly CaM
binding was predicted, by database search, in all species examined.
3.6. Some FADD mutants, in the CaM binding sites, do not bind Fas
To characterize the effect of mutations in the CaM binding sites on
the ability of FADD to mediate protein interactions, we ectopically
expressed, in Hek293T cells, HA-tagged FADD full-length proteins:
wild type, W112A/W148A, W112A/K153A, R114A/W148A and
R114A/K153A along with Fas or TRADD. Co-immunoprecipitation
experiments indicated that only wild type and R114A/K153A FADD
proteins interact with Fas (Fig. 5A) whereas all FADDmutants interact
with TRADD, another DD-containing protein (Fig. 5B). FADD mutants
were expressed at similar levels in all transfection experiments. These
results indicate that some mutations in FADD, that impair CaM
interaction, also impair Fas interaction. Moreover, the data suggest
that CaM and Fas might compete for binding to FADD. Next, com-
plementation experiments in Jurkat FADD−/− I2.1 T cell line,
completely resistant to Fas-mediated apoptosis, showed accordingly
that only the wild type and the R114A/K153A FADD proteins re-
constituted sensitivity to Fas-mediated apoptosis, while the other
FADD mutants, that do not bind Fas, as expected failed (Fig. 5C).
Transfection efﬁciency was similar for all mutants (25–30%) and
accordingly similar protein levels were detected, by western blot, in
total cell lysates (data not shown).
3.7. CKIα binds to CaM and CKIα phosphorylates both CaM and FADD
It has been previously shown that CKIα phosphorylates human
FADD at S194 [16]. Since, CaM regulates the phosphorylation of several
interacting proteins, we decided to investigate the possible interplay of
CaM and CKIα. First, we observed that 35S-Met-human CKIαS (Fig. 6A)
and D. rerio CKIα (Fig. 6B), produced by in vitro transcription and
translation, speciﬁcally bound CaM-sepharose in a calcium dependent
fashion. Next, we set up CKIα kinase assays with a commercial CKI
proteinorD. rerioHis-CKIα anddemonstrated that CKIαphosphorylates
recombinant CaM and X. laevis His–CaM (Fig. 6C, D). Interestingly, the
concentration of Ca2+ strongly inﬂuenced CaM phosphorylation, with
EGTA increasing phosphorylation and Ca2+ interfering with it (Fig. 6C,
D). These results suggest that variations in intracellular Ca2+ concen-
tration might be regulating CaM phosphorylation. We also observed,
as previously reported [16], that CKIα phosphorylates human GST-
FADDΔDED and not -FADD.DD lacking the S194 phosphorylation site
(Fig. 6E).Moreover, we demonstrated that CKIα phosphorylates in vitro
the W112A/K153A and R114A/K153A FADD mutants (Fig. 6F), murine
FADD (mFADD) but not Drosophila FADD (dFADD), which lacks a C-
terminal phosphorylation site (see Supplemental data Fig. S3). To
investigate whether CaM was phosphorylated by CKI expressed in
human cell lines, His–CaM bound to nickel agarose beads was used to
pull-down kinases from HeLaS3 cell extracts and then kinase assays
were performed in presence of CKI-7 (30 and 100 μM). CKI-7 is a kinase
inhibitor that speciﬁcally blocks the activity of all CKI isoforms [19].Remarkably, the additionof CKI-7 in vitro inhibited thekinase activity on
CaM(Fig. 6G), suggesting that CaMcanbephosphorylated, amongother
known kinases [34], by CKI. Moreover, we conﬁrmed, by pull-down
assays, that GST-FADDΔDEDbut not GST-FADD.DDwas phosphorylated
by HeLaS3 kinase activity and that, as expected, FADD phosphorylation
was almost completely abolished by the CKI-7 inhibitor (Fig. 6H).
Finally, we showed that W112A/K153A and R114A/K153A FADD
mutants were also phosphorylated by HeLaS3 kinase (Fig. 6I), while
dFADD was not (see Supplemental data Fig. S3B).
3.8. FADD, CaM and CKIα co-localize on the mitotic spindle
Given our interaction data and the fact that phosphorylated FADD
was shown to co-localize with CKIα at the mitotic spindle poles in
metaphase and early anaphase [16]; we decided to analyze the
temporal and spatial distribution of endogenous FADD, CaM and CKIα
proteins in mitotic cells. HeLa cells were synchronized, by double
thymidine block, to enrich for mitosis and stained with speciﬁc
antibodies. When cells were ﬁxed prior to permeabilization and
examined by immunoﬂuorescence, FADDwas not associated with any
subcellular structures in interphase (data not shown). After the
nuclear envelope breakdown, FADD was diffused throughout the
mitotic cytoplasm and association with speciﬁc structure was only
rarely observed with several antibodies (UBI polyclonal; BD Trans-
ductional Laboratories monoclonal, pFADD Cell Signaling Technology
polyclonal). However, if the cells were subjected to mild extraction
with digitonin, to eliminate soluble proteins before ﬁxation, both the
monoclonal and the UBI polyclonal FADD antibodies decorated the
mitotic spindle with a discrete pattern. During metaphase FADD,
was mainly concentrated at the polar regions of the spindle and
remarkably co-localized with CaM and with CKIα (Fig. 7A, B). In early
anaphase FADDwas both at polar and central regions of the spindle, in
anaphase and late anaphase it became more concentrated at the
central region. Interestingly in anaphase and late anaphase both CaM
and CKIα, co-localized with FADD to the central spindle (Fig. 7A, B). In
telophase the FADD signals decreased. CaM and CKIα co-localizes in
all mitotic phases at the spindle (Fig. 7C). With the pFADD reactive
polyclonal antibody, in our experimental conditions, we did not
obtain a convincing and reproducible staining pattern; thus the local-
ization of unphosphorylated and phosphorylated FADD in all mitotic
phases should be further investigated.
3.9. FADD mutants in the CaM binding sites protect Jurkat T cells from
Taxol-induced G2/M cell cycle arrest
It has been previously reported that cell sensitivity to Taxol can be
modulated by the phosphorylation status of FADD and that FADD
regulates mitosis at a stage targeted by tubulin-disrupting reagents
[16]. In order to investigate the role of FADD/CaM interaction in
mitosis, cell lines stably expressing FADD proteins with mutations in
the CaM binding sites were produced. Brieﬂy, Jurkat FADD−/− cells
were infected with retrovirus FADD expression vectors and selected
with puromycin. Cell lines expressing wild type, W112A/K153A, and
R114A/K153A FADD proteins were synchronized by double thymi-
dine block and the cell cycle proﬁle of untreated or Taxol treated cells
were analyzed by PI staining and cytoﬂuorimetric analysis. No
signiﬁcant differences in cell cycle distribution were observed
among the cell lines when untreated. Accordingly a similar ratio of
the percentage of cells in G2 relative to the percentage of cells in G1 of
the cell cycle (G2/G1 ratios) was obtained (Fig. 8A, B). After exposure
to Taxol the G2/G1 ratio, representative of the percentage of cells
which accumulate in the G2/M phase, was higher in Jurkat cell lines
expressing a wild type FADD protein than in the FADD−/− cells
infected with empty vector or FADD mutants (Fig. 8A, B). FADD
phosphorylation was observed upon Taxol treatment in all cell lines.
Fig. 6. CKIα interacts with CaM and phophorylates CaM and FADD. A: 35S-Met-human HA-CKIαS produced by in vitro transcription and translation, was incubated with CaM-
sepharose or Ctrl (protein A-sepharose) beads in binding buffer with Ca2+ or EGTA as indicated. Bound proteins were eluted in Laemmli reducing sample buffer and 50% of the
reactions were analyzed by SDS-PAGE and autoradiography. The input (I) was 1/20 of the translation reaction used in the binding assay. B: 35S-Met-CKIα from Danio reriowas used
in binding assays with CaM-sepharose as described in A. C, D: Xenopous laevis His–CaM and CaM from UBI (rCaM) were incubated with c-CKI (5 U Promega) (C), or Danio rerio His-
CKIα (D) with γ-ATP in kinase buffer. Autoradiograms in C and D are shown in b, * in D (b) indicates the autophosphorylation bands of His-CKIα and the arrow the bands
corresponding to phosphorylated CaM. In D (a) is shown the coomassie staining. E, F: Kinase assays with the GST-FADD proteins indicated and c-CKI (Promega) or Danio rerio His-
CKIα as in C and D. Panel (a) show the coomassie staining and panel (b) the autoradiograms; * indicates the autophosphorylation bands of His-CKIα and the arrow the
phosphorylated FADD proteins. G: His–CaM pull-down and kinase assay with HeLaS3 cell extracts in absence or presence of the CKI-7 inhibitor (30 or 100 μM). In panels (a) and (b)
are shown respectively the coomassie stainings and the autoradiograms. The relative phosphorylation levels of His–CaM are presented below the autoradiogram, where 80 was with
30 μM of CKI-7 and 64 with 100 μM. H, I: GST-FADD pull-down and kinase assay with HeLa cell extracts as in G. In I ctrl indicates GST protein. The data are representative of at least
three independent experiments.
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Fig. 7. FADD, CaM and CKIα co-localize to the mitotic spindle in metaphase and anaphase. Immunoﬂuorescence analysis of synchronized HeLa cells at different mitotic stages. Cells
were stained (see Materials and methods for details) with FADD (UBI or BD Transduction Laboratories) (A, B, C), CKIα (B, C) and CaM (Santa Cruz) (A, C) reactive antibodies as
indicated and nuclei were visualized with DAPI. Representative images are shown. Bar, 10 μm.
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909G. Papoff et al. / Biochimica et Biophysica Acta 1803 (2010) 898–911The results suggest that cell sensitivity to Taxol-mediated G2/M cell
cycle arrest can be modiﬁed by altering FADD–CaM interaction.
4. Discussion
FADD is a protein that regulates cell fate mainly but not only
through interactions with proteins sharing homologous DD and DED
interaction domains. Here, we demonstrate that FADD interacts with
CaM, a protein devoid of homologous domains and remarkably
implicated in a large number of cellular events including cell cycle and
apoptosis.
We demonstrate that CaM interacts with the DD of FADD in a Ca2+-
dependent fashion.Alaninepointmutations in the twopredictedbinding
sites and in vitrobinding assays allowedus tomap the regionspotentially
involved in FADD/CaM interaction. In fact, mutations ofW112 and R114
in α helix 8 and of R146, W148 and K153 in α helix 10 and the loop
connecting α helices 10 and 11 impair FADD/CaM interaction.
FADD has been extensively mutated in the DD in an effort to
identify the surface of FADD responsible for interaction with activated
Fas, Tumor necrosis factor 1 (TNFR1) and TRADD [49,51–53]. Based on
the three-dimensional structure of Drosophila Tube DD bound to the
DD of Pelle kinase [54] and on mutagenesis studies it has been
proposed that FADD uses a Tube-like surface to interact with both Fas
and TRADD adaptor protein [52,53]. Interestingly, α helix 8 is located
on the Tube-like surface; thus, CaM could potentially regulate,
through FADD binding, Fas and TNFR1 signaling or TRADD-dependent
processes. Infact, it has been shown that alanine substitutions in α
helices 8 and 9 abrogated or decreased the binding afﬁnity of FADD to
Fas including the R114A in α helix 8 [49]. Intriguingly, our data
showed that FADD R114A/K153A co-immunoprecipitated with Fas
and reconstituted Fas-mediated apoptosis in Jurkat JA3 FADD−/−
cells. More recent mutagenesis and functional studies on Fas and
FADD interaction proposed that the major surface of FADD.DD
involved in Fas interaction is composed of elements in α helices 7,
8, 9, 11, and 12; while a secondary surface that involves residues in α
helices 9 and 10 and that resides on the opposite face of the domain
should be involved in DISC stabilization [52,53]. The CaM binding site
in α helix 10 and in the loop between α helices 10 and 11, involving
residues R146 and K153, should be located on the surface of FADD
suggested playing a role in DISC assembly more than in Fas or TRADD
binding. These mutagenesis and prediction models well match with
the solved structure of FADD [1]. However, in the Fas–FADD
interaction picture it should also be considered that the recently
solved structure of a soluble Fas.DD/FADD.DD complex showed weak
interactions of Fas and FADD even if large binding areas are available
[55]. In the Fas.DD–FADD.DD complex, the interface was formed
essentially by α helices 1 and 6 of FADD DD [55].
Our analysis of FADD mutants in vivo indicates that Fas and CaM
might compete for binding to FADD, in fact the mutants W112A/
W148A, R114A/W148A and W112A/K153A did not co-immunopre-
cipitated with Fas, when ectopically expressed in Hek 293T cells, and
did not reconstitute agonistic antibody-mediated apoptosis in the
FADD−/− Jurkat T cell line. It has been recently reported that W148
and to some extent W112 are important to FADD structure, native
state stability and folding [56]. Moreover, to elucidate the relative
importance of secondary structure and topology in determining
folding mechanism, a phi-value analysis of the FADD.DD was recently
carried out [57]. To obtain Φ-values for core residues and residues
within elements of secondary structure, 64 mutations were made: 23Fig. 8. FADD mutants, in the CaM binding sites, protect Jurkat cells from Taxol-induced G2/
FADD−/− cells, infected with retroviral vectors expressing wild type or mutated FADD prot
double thymidine block, were cultured without or with Taxol for 16 h. A: Representative cy
B: Cell cycle analysis data of samples culturedwithout (black bars) orwith Taxol at 10 nM(gre
of 3 independent experiments and are represented as the ratio of the percentage of cells in G
derived Jurkat cell lines expressing wild type and W112/K153A FADD proteins were used in
antibody (BD Transduction Laboratories) in total cell lysates of untreated or Taxol treated saof these were mutations of core residues. Mutations were designed to
determine which regions of the protein were fully unfolded, partially
folded or fully folded in the transition state (TS). The mutations were
located on elements of the three FADD cores, B1 (helices 1, 5 and 6),
B2 (helices 2, 3 and 4) and central (parallel helices 1–5 and 2–4) [57].
The picture emerged by this study is that FADDDD folds in a simple
two-state manner with no stable kinetic or equilibrium intermediate.
It has been suggested that in the TS all three cores are only partially
structured. In such analysisW112A andW148Fmutationswere shown
to affect several numbers of contacts respectively in the B2 core and in
the central core [57].Φ-value forW112wasmedium and data analysis
of mutants mapping to the B2 core indicated that in the TS this core is
loosely structured. Moreover, the central core in TS appeared only
partly formed. Notably, while in the native state, the central core of
FADD DD is dominated by W148 in helix 4, this region in the central
core appears to be largely unstructured in the TS [57].
We showed that FADD double mutants containing alanine
substitutions in W112 and W148 residues still interacts with FADD
wild type and TRADD however in light of the above studies the
possibility that lack of interaction with Fas of some FADD mutants,
involving tryptophane residues, was due to structural modiﬁcation or
partial unfolding of FADD should be considered. The effect of double
mutations on the full length protein folding and eventually the
contribution of interacting protein partners on it will require further
investigation.
So far few structural data on complexes mediated by members of
the death domain superfamily have been disclosed. Moreover, several
reports suggest that both FADD and CaM may go through conforma-
tional changes when interacting with other proteins i.e. Fas.DD-FADD.
DD, Fas.DD-CaM and CaM-DAPK.
The human death domain superfamily consists of 86 members: 26
Caspase recruitment domains (CARDs), 32 DDs, 7DEDs and 19 Pyrin
domains (PYDs) [58]. Only four complexes, involving homologous
interactions, have been structurally characterized: i. Fas.DD and FADD.
DD [55]; ii Caspase-9 CARD and Apaf1 CARD involved in the
apoptosome-mediated intrinsic apoptotic signaling pathway [59];
iii. the DD of Drosophila Tube and Pelle [54]; iv. the structure of PYDD
DD and RAIDD DD that interact upon DNA damage in the PIDDosome
complex to regulate cell fate [60].
The structure of the soluble Fas.DD/FADD.DD complex showed a
tetrameric arrangement with four FADD.DD bound to four Fas.DD, a
dimer of two Fas–FADD DDs complex dimers [55]. Very interestingly,
the Fas.DD in the complex had undergone through remarkable
structural changes when compared to the isolated/unbound Fas DD.
The Fas.DD showed a signiﬁcant open transition in the complex, to
create binding sites for the FADD.DD, absent in the unbound and
closed form. The opening of Fas DD generated FADD binding sites and
homotypic interactions of Fas DD-Fas DD. The open transition was
essentially due to the fusion of helices 6 and 5 and as a result a portion
of the hydrophobic core of Fas becomes exposed. Overall such
complex features led to the description of a “conditional domain
interaction” regulating DISC assembly in which upon Fas ligand
binding the open and unstable forms of Fas can interact and stabilize
each other tomake the binding sites for FADD available. Importantly, a
FADD.DD conformational change, even if not dramatic as the opening
of Fas, was also observed and suggested to be potentially involved in
the ampliﬁcation of the “off–on” switch [55]. Unfortunately the lack of
information on the contribution of the FADD.DED on complex
assembly and Fas–FADD interaction make the picture still incomplete.M cell cycle arrest. Sensitivity to Taxol-mediated G2/M arrest was measured in Jurkat
eins, by propidium iodide staining and cytoﬂuorimetric analysis. Cells synchronized, by
toﬂuorimetric proﬁles of cells cultured without (a) or with 10 nM Taxol (b) are shown.
y bars) or 20 nM(white bars) concentration are shown. Results in B are the average±SD
2 relative to the percentage of cells in the G1 phase of the cell cycle. Two independent
all experiments and shown in panel B. C: Western blot detection of FADD by a speciﬁc
mples as indicated.
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bind CaM: the Fas receptor, containing a DD and the cellular FLICE
inhibitory protein (FLIP), containing a DED [43,61]. Variation in Fas-
CaM and Fas-FLIP binding was observed upon Fas stimulation [43,61].
Interestingly, conformation studies and free-energy calculations of
the CaM/Fas.DD complex revealed that the binding of CaM to Fas
results in conformational changes of both CaM and Fas that stabilize
their structures, and affects the degree of correlated motion of the
residues in both CaM and Fas [62].
The stoichiometry of FADD and CaMmolecules in the complex and
the CaM regions involved in the interaction are still unknown and
potentially important in the regulation of FADD function. In our
experimental conditions we did not detect interaction of CaM with
the N-terminal DED of FADD or the DED1 and DED2 of Procaspase-
8 (data not shown) however we cannot exclude that the DED in the
overall structure of FADD might contribute to the interaction of FADD
and CaM.
Recently, the structure of CaM in complex with the Death-
associated protein kinase (DAPK) (1–334) was compared with that
of CaM in complex with the DAPK (302–320) peptide and an
unexpected degree of conformational difference between the two
complexes was reported [63]. When bound to the protein, the two
CaM lobes opened into an extended conformation, while they had a
compact overall arrangement with the helical peptide.
Taking into account these literature data, at this stage it is difﬁcult
to further speculate on the FADD–CaM interaction sites/surfaces.
We showed that CaM interacts with both phosphorylated and
unphosphorylated FADD protein and that FADD mutants can be
phosphorylated by CKIα suggesting that FADD/CaM interaction is not
required for FADD phosphorylation. However, it is still open the
possibility that FADD/CaM interaction regulates this important post-
translation modiﬁcation and/or FADD dephosphorylation. We also
attempt to co-immunoprecipitate endogenous FADD and CaM
proteins from post-nuclear mammalian cell lysates with no success.
These negative data could be due to technical constraints but could
also suggest that FADD/CaM interaction is a dynamic and regulated
event likely in mitosis.
Complementation experiments in Jurkat FADD−/− cells by retro-
viral infection, synchronization and Taxol-induced cell cycle arrest
experiments nicely indicate that cells expressing FADD at physiological
levels, indistinguishable from the one expressed by Jurkat JA3 parental
FADD+/+ cells, are protected from Taxol-induced G2/M cell cycle
arrest pointing out to a potential role for FADD/CaM interaction in cell
cycle regulation. Here, we also demonstrated that CKIα interacts with
CaM and that CKIα phosphorylates FADD, as previously reported [16],
and CaM. Theseﬁndings suggest the possibility that a complex interplay
of these three proteins related to their subcellular distribution,
phosphorylation, dephosphorylation and calcium-regulated interac-
tions might be involved in cell cycle regulation. Remarkably, in
synchronized HeLa cells, FADD co-localizes with both CaM and CKIα
at themitotic spindle. The three proteins show co-localizationmainly at
the spindle poles in methaphase and in ﬁber-like structures at the
midzone region in anaphase. It is known that progression through G1
and exit from mitosis are sensitive to changes in the intracellular
concentrations of calciumandCaMand that the addition of speciﬁc anti-
CaM drugs to cell cultures inhibits the reentry of growth-arrested cells
into the cell cycle (G0/G1 transition), theprogression into and throughS
phase and the entry and exit from mitosis [25,26,64–66]. It is thus
interesting that the interaction of CaM with both FADD and CKIα is
calcium dependent, while the CKIα-mediated phosphorylation of CaM
increases with low calcium levels and EGTA at least in vitro. We
speculate that unveiling the dynamic interplay of FADD, CaM and CKIα
might shed light on the role of FADD in cell proliferation and cell cycle
control. Thus, the elucidation of the mechanisms by which FADD/CaM
interaction, FADD phosphorylation and dephosphorylation affect cell
cycle progression deserves further investigation.Finally, wewould like to point out that the interaction of FADD and
CaM is evolutionarily conserved in human, mouse and Drosophila. The
interaction of dFADD with CaM is particularly interesting for two
reasons; ﬁrst because dFADD does not contain a phosphorylation C-
terminal site and second because Drosophila has no death receptor
homologs. The only functional role, so far described, for dFADD is in
the signal transduction Imd pathway triggered by gram-negative
bacteria and culminating in the expression of genes encoding
antimicrobial peptides [67,68]. Thus the possible role of FADD/CaM
interaction in the antibacterial innate immunity response should be
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